1. Home
  2. ECBK vs ASMB Comparison

ECBK vs ASMB Comparison

Compare ECBK & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECBK
  • ASMB
  • Stock Information
  • Founded
  • ECBK 1919
  • ASMB 2005
  • Country
  • ECBK United States
  • ASMB United States
  • Employees
  • ECBK N/A
  • ASMB N/A
  • Industry
  • ECBK Banks
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECBK Finance
  • ASMB Health Care
  • Exchange
  • ECBK Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • ECBK 151.0M
  • ASMB 141.8M
  • IPO Year
  • ECBK N/A
  • ASMB 2010
  • Fundamental
  • Price
  • ECBK $16.11
  • ASMB $18.51
  • Analyst Decision
  • ECBK
  • ASMB Strong Buy
  • Analyst Count
  • ECBK 0
  • ASMB 3
  • Target Price
  • ECBK N/A
  • ASMB $33.00
  • AVG Volume (30 Days)
  • ECBK 67.3K
  • ASMB 43.3K
  • Earning Date
  • ECBK 08-08-2025
  • ASMB 08-07-2025
  • Dividend Yield
  • ECBK N/A
  • ASMB N/A
  • EPS Growth
  • ECBK 17.87
  • ASMB N/A
  • EPS
  • ECBK 0.57
  • ASMB N/A
  • Revenue
  • ECBK $26,906,000.00
  • ASMB $32,154,000.00
  • Revenue This Year
  • ECBK N/A
  • ASMB $0.04
  • Revenue Next Year
  • ECBK N/A
  • ASMB N/A
  • P/E Ratio
  • ECBK $28.65
  • ASMB N/A
  • Revenue Growth
  • ECBK 5.99
  • ASMB 148.33
  • 52 Week Low
  • ECBK $12.50
  • ASMB $7.75
  • 52 Week High
  • ECBK $16.99
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • ECBK 59.98
  • ASMB 63.34
  • Support Level
  • ECBK $15.78
  • ASMB $18.13
  • Resistance Level
  • ECBK $16.45
  • ASMB $19.11
  • Average True Range (ATR)
  • ECBK 0.39
  • ASMB 0.81
  • MACD
  • ECBK 0.10
  • ASMB -0.06
  • Stochastic Oscillator
  • ECBK 85.54
  • ASMB 77.83

About ECBK ECB Bancorp Inc.

ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: